This is a Validated Antibody Database (VAD) review about cow TGFBR1, based on 3 published articles (read how Labome selects the articles), using TGFBR1 antibody in all methods. It is aimed to help Labome visitors find the most suited TGFBR1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TGFBR1 synonym: TGF-beta receptor type-1; TGF-beta receptor type I; TGF-beta type I receptor; TGFR-1; tbetaR-I; transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa); transforming growth factor-beta receptor type I

Abcam
rabbit polyclonal
  • western blot; mouse; fig 6d
Abcam TGFBR1 antibody (Abcam, ab31013) was used in western blot on mouse samples (fig 6d). Basic Res Cardiol (2017) ncbi
rabbit polyclonal
  • western blot; mouse; fig 6c
In order to explore the roles of activated portal fibroblasts and myofibroblasts in the pathogenesis of liver fibrosis induced by bile duct ligation, Abcam TGFBR1 antibody (Abcam, aB31013) was used in western blot on mouse samples (fig 6c). J Clin Invest (2017) ncbi
rabbit polyclonal
  • western blot; mouse; 1:500; fig 3
In order to discuss the role of Beclin 1 in neurodegeneration, Abcam TGFBR1 antibody (Abcam, ab31013) was used in western blot on mouse samples at 1:500 (fig 3). Mol Neurodegener (2015) ncbi
Articles Reviewed
  1. Wang Q, Yu Y, Zhang P, Chen Y, Li C, Chen J, et al. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Basic Res Cardiol. 2017;112:47 pubmed publisher
  2. Koyama Y, Wang P, Liang S, Iwaisako K, Liu X, Xu J, et al. Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. J Clin Invest. 2017;127:1254-1270 pubmed publisher
  3. O Brien C, Bonanno L, Zhang H, Wyss Coray T. Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5. Mol Neurodegener. 2015;10:69 pubmed publisher